ArcherDX and Illumina partner to broaden access for oncology testing

ArcherDX and Illumina partner to broaden access for oncology testing

BOULDER -- ArcherDX, Inc . announced a non-exclusive, multi-year partnership with San Diego-based Illumina, Inc. (NASDAQ: ILMN) that aims to broaden access of next generation sequencing (NGS)-based... Read More

Monday January 13, 2020 0 comments Tags: Boulder, ArcherDx, Jason Myers, Illumina, Phil Febbo

ArcherDX partners with Illumina to develop in-vitro diagnostic tests

ArcherDX partners with Illumina to develop in-vitro diagnostic tests

BOULDER -- ArcherDX, Inc. , a growth-stage molecular diagnostics company dedicated to developing breakthrough solutions that advance personalized genomic medicine, today announced a non-exclusive... Read More

Tuesday December 3, 2019 0 comments Tags: Boulder, ArcherDx, Illumina, Jason Myers, Phil Febbo